Product Images Flumazenil

This text describes a study that investigates the effects of different doses of Flumazenil on the reversal of sedation caused by midazolam infusion in healthy volunteers. The doses tested were 0.2mg, 0.6mg, and 1mg, and their corresponding blood levels were measured in ng/mL. The study monitored the alertness of the participants for up to 100 minutes after the Flumazenil injection.*

This is a description of a medicine called Flumazenil Injection, USP. It is a sterile solution meant for intravenous use only. The 5 mL multi-dose vial contains 0.1 mg of Flumazenil mixed with water. Other ingredients include 9 mg Sodium Chloride, 0.1 mg Edetate Disodium Dihydrate, and 0.1 mg Glacial Acetate Adi; the pH is adjusted to 3.4 to 4.6 with Hydrochloric Acid and/or Sodium Hydroxide. The medicine should be stored between 20° to 25°C (68°to TT°F) and should be protected from light. It should not be frozen. The usual dosage is mentioned on the package insert.*

This is a description of the drug Flumazenil. It is administered through injection, USP, for intravenous use only. It is packaged in ten multi-dose vials, with 5mL in each vial, and is manufactured by Baxter Healthcare Corporation. Additional details include the NDC number 36000-148-10, AIN code AIN00213, the drug's RX Only status, and manufacturing and expiry dates. There is also space for a 2D barcode and varnish-free area.*